000 | 01989 a2200541 4500 | ||
---|---|---|---|
005 | 20250516190248.0 | ||
264 | 0 | _c20140923 | |
008 | 201409s 0 0 eng d | ||
022 | _a1878-1519 | ||
024 | 7 |
_a10.1016/j.resp.2013.12.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRighetti, Renato Fraga | |
245 | 0 | 0 |
_aEffects of Rho-kinase inhibition in lung tissue with chronic inflammation. _h[electronic resource] |
260 |
_bRespiratory physiology & neurobiology _cFeb 2014 |
||
300 |
_a134-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAmides _xadministration & dosage |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aCytokines |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
650 | 0 | 4 |
_aLung _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aOvalbumin _xadverse effects |
650 | 0 | 4 |
_aPneumonia _xetiology |
650 | 0 | 4 |
_aPyridines _xadministration & dosage |
650 | 0 | 4 | _aStress, Mechanical |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
650 | 0 | 4 |
_arho-Associated Kinases _xmetabolism |
700 | 1 | _aPigati, Patricia Angeli da Silva | |
700 | 1 | _aPossa, Samantha Souza | |
700 | 1 | _aHabrum, Fábio Cetinic | |
700 | 1 | _aXisto, Débora Gonçalves | |
700 | 1 | _aAntunes, Mariana Alves | |
700 | 1 | _aLeick, Edna Aparecida | |
700 | 1 | _aPrado, Carla Máximo | |
700 | 1 | _aMartins, Mílton de Arruda | |
700 | 1 | _aRocco, Patrícia Rieken Macedo | |
700 | 1 | _aTibério, Iolanda de Fátima Lopes Calvo | |
773 | 0 |
_tRespiratory physiology & neurobiology _gvol. 192 _gp. 134-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.resp.2013.12.012 _zAvailable from publisher's website |
999 |
_c23401101 _d23401101 |